EU MDR Article 120 Legacy Devices: What You Must Do Before Deadline
EU MDR Article 120 transition deadlines for legacy devices. Understand your obligations, QMS requirements, and what happens if you miss the deadline.
Deep dives into FDA compliance, EU MDR, QMSR, and medical device regulatory strategy.
Join 2,500+ medical device professionals who start their day with RegWatch Daily.
Daily briefings on FDA, EU MDR, QMSR, and 510(k) — filtered for your role.
EU MDR Article 120 transition deadlines for legacy devices. Understand your obligations, QMS requirements, and what happens if you miss the deadline.
IEC 62304 software development lifecycle requirements for medical devices. Software safety classes, documentation, and what FDA and EU MDR expect from your software team.
How to conduct a Failure Mode and Effects Analysis (FMEA) for medical devices under ISO 14971. Severity, probability, risk evaluation, and risk control documentation.
Compare FDA 21 CFR Part 820 QSR and ISO 13485:2016 QMS requirements. What changed under QMSR and how to build a harmonized quality system.
Prepare for your EU MDR Notified Body audit. Understand the audit stages, documentation requirements, common findings, and how to manage the audit process.
Complete guide to the FDA 510(k) clearance pathway for Class II medical devices. Predicate selection, substantial equivalence, testing requirements, and realistic timelines.
Complete guide to EU IVDR 2017/746 compliance for IVD manufacturers. Device classification, performance evaluation, EUDAMED, and transition deadlines.
How to conduct IQ, OQ, and PQ process validation for medical devices under FDA QMSR and ISO 13485. Validation protocols, acceptance criteria, and revalidation requirements.
Concrete action items for transitioning from FDA QSR to QMSR by February 2027. Gap analysis, documentation updates, training requirements, and inspection readiness.
Build an FDA-compliant complaint handling procedure for medical devices. 21 CFR 820.198 and MDR 21 CFR Part 803 requirements, complaint investigation, and MDR reportability.
What FDA expects for medical device audit trails under 21 CFR Part 820 and QMSR. Electronic records, document control logs, and how audit trails are reviewed during inspections.
EU MDR PMCF requirements under Article 61 and Annex XIV. What goes in a PMCF plan, PMCF evaluation report, and how to build a PMCF program that satisfies Notified Bodies.
How to complete FDA establishment registration and device listing for medical device manufacturers. Annual renewal requirements, 510(k) exemptions, and common mistakes.
How to conduct biocompatibility evaluation for medical devices under ISO 10993. Risk-based approach, material characterization, biological testing, and FDA submission requirements.
How to conduct accelerated aging studies for medical device shelf life validation. ASTM F1980, Q10 method, real-time aging, and FDA submission requirements.
How to build and run an internal audit program for ISO 13485:2016. Audit planning, auditor competency, conducting audits, nonconformance reporting, and CAPA integration.
What goes in a Design History File under FDA 21 CFR 820.30. DHF structure, required records, common gaps, and how to maintain a DHF that passes inspection.
How to validate sterilization processes for medical devices. ISO 11135 (EtO) and ISO 11137 (radiation) requirements, bioburden, cycle development, and revalidation.
When to use FDA's De Novo classification pathway for novel medical devices. De Novo request preparation, decision criteria, and how De Novo clearance creates a 510(k) predicate.
How to implement EU MDR UDI requirements and register devices in EUDAMED. UDI-DI and UDI-PI structure, issuing agencies, labeling requirements, and EUDAMED submission.
How to design and submit an FDA Investigational Device Exemption (IDE) application. Significant vs non-significant risk, IDE content requirements, and study design considerations.
What belongs in a medical device risk management file under ISO 14971:2019. Risk management plan, risk analysis, evaluation, controls, and residual risk documentation.
FDA recall Class I, II, and III definitions for medical devices. When a recall is required, how to initiate one, recall strategy requirements, and FDA oversight of recall effectiveness.
A complete guide to FDA 21 CFR 820.100 CAPA requirements for medical device manufacturers. Learn how to build a compliant CAPA procedure that satisfies FDA inspections and ISO 13485.
A complete guide to the EU MDR Summary of Safety and Clinical Performance (SSCP) requirement for Class III and implantable devices. What must be included, how it is validated, and how to write one.
How to identify, evaluate, and document a predicate device for FDA 510(k) substantial equivalence. What makes a valid predicate, how to handle performance differences, and common FDA rejection reasons.
Today’s regulatory updates include FDA approvals for a pulmonary hypertension detection algorithm, gene therapy for severe Leukocyte Adhesion Deficiency Type I, and an HIV screening assay from Roche.
Stay ahead of regulatory changes: photon-counting CT technology, EU MDR compliance, FDA approvals and initiatives.
The QMSR transition deadline is February 2, 2027. Learn what changed, what stays the same, and how to align your QMS with the new FDA requirements.
Received an FDA 483? Learn how to write an effective response, what FDA expects, common mistakes to avoid, and examples of good vs bad responses.
43% of 510(k) submissions get RTA'd. Learn the top reasons for Refuse to Accept, how to use FDA's RTA checklist, and what to include to pass screening.
Stay ahead of regulatory changes with updates on photon-counting CT technology, FDA approvals, and MDR compliance.
Stay ahead of the curve with today's critical regulatory updates from major medical device companies and FDA approvals.
What FDA expects in a Warning Letter response: 15-day timeline, response structure, root cause analysis standard, CAPA closure evidence requirements, and common mistakes that keep Warning Letters open.
FDA now accepts adaptive designs, Bayesian methods, and master protocols for device pivotal studies. What changed and how to use it in your IDE and SAP.
How to build a PCCP FDA will approve for AI/ML-based medical devices. What your change scope, performance bounds, and monitoring plan must specify.
How FDA's Real World Evidence program applies to device 510(k), De Novo, and PMA submissions. Data governance requirements and building RWE capability early.
What FDA's 2023 cybersecurity guidance requires in premarket submissions. SBOM, threat modeling, post-market monitoring, and what triggers a refusal to accept.
EU MDR and IVDR requirements for medical device manufacturers. Clinical evaluation, technical documentation, notified body selection, and EUDAMED registration.
What MDSAP auditors actually examine across the 7 audit chapters. Common finding categories, preparation priorities, and how to structure your evidence packages.
What FDA QMSR §820.30 and ISO 13485 §7.3 require for medical device design controls. Design inputs vs outputs, V&V requirements, DHF structure, design transfer, and common FDA 483 observations.
What your post-market surveillance plan must include under ISO 13485 §8.2 and EU MDR Article 83. PMCF obligations, PSUR requirements, and common PMS gaps FDA and notified bodies flag.
What FDA expects from Software as a Medical Device (SaMD): IEC 62304 classification, SOUP management, PCCP for AI/ML devices, cybersecurity submission requirements, and when a 510(k) is required.
What FDA QMSR §820.50 and ISO 13485 §7.4 require for medical device supplier qualification. Supplier evaluation, quality agreements, ASL, incoming inspection, and common FDA 483 observations.
What FDA QMSR §820.100 and ISO 13485 §8.5 require for CAPA. Root cause vs symptom, effectiveness verification, trending for management review, and the top FDA 483 patterns in CAPA systems.
Free FDA compliance readiness calculator for medical device companies. Answer 8 questions and get your score plus recommended resources.
Practical ISO 14971:2019 risk management guide for medical devices. Learn pFMEA, residual risk evaluation, risk-benefit analysis, and key changes from the 2007 edition.
Navigate FDA and EU MDR dual compliance for medical devices. Gap analysis framework, document control strategies, and timeline for selling in both US and EU markets.
Prepare for your MDSAP audit with this guide covering all 5 regulatory authorities, the scoring model, audit sequence, and top preparation mistakes to avoid.
Complete FDA 510(k) RTA checklist to avoid Refuse to Accept. Learn what triggers RTA, predicate device selection, and common submission failures.
Step-by-step QMSR transition guide for medical device manufacturers. Learn the FDA Part 820 to ISO 13485 alignment timeline, common mistakes, and how to adapt your QMS.